Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2016. Start Trial.
Date Value
November 19, 2026 2.336M
November 18, 2026 3.170M
November 17, 2026 4.489M
November 16, 2026 6.156M
November 13, 2026 5.322M
November 12, 2026 3.302M
November 11, 2026 5.149M
November 10, 2026 4.836M
November 09, 2026 5.322M
November 06, 2026 4.911M
November 05, 2026 4.767M
November 04, 2026 5.531M
November 03, 2026 6.642M
November 02, 2026 7.267M
October 30, 2026 7.545M
October 29, 2026 7.684M
October 28, 2026 8.448M
October 27, 2026 8.864M
October 26, 2026 9.698M
October 23, 2026 9.073M
October 22, 2026 8.240M
October 21, 2026 8.552M
October 20, 2026 9.490M
October 19, 2026 9.628M
October 16, 2026 10.74M
Date Value
October 15, 2026 10.84M
October 14, 2026 9.906M
October 13, 2026 12.34M
October 12, 2026 12.68M
October 09, 2026 13.38M
October 08, 2026 12.68M
October 07, 2026 13.03M
October 06, 2026 12.58M
October 05, 2026 12.48M
October 02, 2026 13.93M
October 01, 2026 12.75M
September 30, 2026 19.63M
September 29, 2026 25.31M
September 28, 2026 25.19M
September 25, 2026 25.50M
September 24, 2026 25.72M
September 23, 2026 26.39M
September 22, 2026 27.61M
September 21, 2026 26.28M
September 18, 2026 26.22M
September 17, 2026 26.28M
September 16, 2026 25.97M
September 15, 2026 25.97M
September 14, 2026 28.92M
September 11, 2026 27.60M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Abbott Laboratories 207.35B
AngioDynamics, Inc. 433.25M
Alphatec Holdings, Inc. 1.596B
AtriCure, Inc. 2.665B
Baxter International, Inc. 19.15B